
Reset all filters
01 2Nauzelin
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2017 Revenue in Millions : 24
2016 Revenue in Millions : 31
Growth (%) : -22
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 19
2017 Revenue in Millions : 23
Growth (%) : -17%